Trials / Sponsors / Jonathan Brammer
Jonathan Brammer
Academic / Other · 3 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma T-cell Lymphoma, Graft Versus Host Disease, Lymphoma, T-Cell | Phase 2 | 2026-02-12 |
| Recruiting | Ruxolitinib for the Treatment of T-Cell Large Granular Lymphocytic Leukemia T-Cell Large Granular Lymphocyte Leukemia | Phase 2 | 2023-05-03 |
| Active Not Recruiting | Oral Azacitidine for the Treatment of Relapsed or Refractory T-cell Large Granular Lymphocytic Leukemia T-Cell Large Granular Lymphocyte Leukemia | Phase 1 / Phase 2 | 2022-06-29 |